Elite Diagnostic Limited (JMSE:ELITE)
Jamaica · Delayed Price · Currency is JMD 1.390
0.00 (0.00%)
At close: Jul 24, 2026
Elite Diagnostic Financials Overview
Financials in millions JMD. Fiscal year is July - June.
Millions JMD. Fiscal year is Jul - Jun.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Revenue Revenue Growth | 875.78 | 853.82 | 821.28 | 755.33 | 624.22 | 506.91 |
Revenue Growth | 0.32% | 3.96% | 8.73% | 21.00% | 23.14% | 15.26% |
Gross Profit Gross Profit Growth | 617.3 | 584.14 | 543.16 | 478.06 | 400.64 | 306.4 |
Operating Income Operating Income Growth | 93.96 | 71.38 | 96.54 | 64.71 | 82.45 | 29.58 |
Net Income Net Income Growth | 48.88 | 32.02 | 26.16 | 13.35 | 48.66 | 1.93 |
Earnings Per Share EPS Growth | 0.14 | 0.09 | 0.07 | 0.04 | 0.14 | 0.01 |
EPS Growth | 33.10% | 22.44% | 95.91% | -72.56% | 2422.72% | -77.45% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Cash & Investments Cash & Investments Growth | 204.07 | 225.55 | 37.22 | 53.88 | 75.89 | 63.99 |
Total Debt Total Debt Growth | 448.1 | 472.33 | 454.52 | 544.32 | 401.66 | 208.93 |
Net Cash (Debt) Net Cash Growth | -244.03 | -246.78 | -417.3 | -490.44 | -325.77 | -144.94 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -0.69 | -0.70 | -1.18 | -1.39 | -0.92 | -0.41 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 182.85 | 260.57 | 164.81 | 111.88 | 147.92 | 125.04 |
Capital Expenditures CapEx Growth | -108.44 | -92.62 | -72.53 | -137.75 | -275.79 | -86.24 |
Free Cash Flow Free Cash Flow Growth | 74.41 | 167.95 | 92.29 | -25.87 | -127.87 | 38.8 |
Free Cash Flow Growth | -47.41% | 81.98% | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Gross Margin | 70.48% | 68.41% | 66.14% | 63.29% | 64.18% | 60.45% |
Operating Margin | 10.73% | 8.36% | 11.76% | 8.57% | 13.21% | 5.83% |
Pretax Margin | 6.18% | 4.32% | 3.57% | 1.77% | 7.80% | 0.38% |
Profit Margin | 5.58% | 3.75% | 3.19% | 1.77% | 7.80% | 0.38% |
FCF Margin | 8.50% | 19.67% | 11.24% | -3.43% | -20.48% | 7.65% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 27, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.010 | 0.010 | - | - | 0.020 | 0.090 |
Dividend Per Share Growth | 0% | - | - | - | -77.78% | - |
Dividend Yield | 0.72% | 0.67% | - | - | 0.57% | 3.12% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 27, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
PE Ratio | 10.05 | 16.66 | 20.94 | 58.50 | 25.71 | 549.56 |
P/FCF Ratio | 6.60 | 3.18 | 5.94 | - | - | 27.32 |
PS Ratio | 0.56 | 0.63 | 0.67 | 1.03 | 2.00 | 2.09 |